These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2124097)

  • 1. Re-infection in human schistosomiasis mansoni: a prospective field study 18 months after praziquantel therapy.
    Zwingenberger K; Harms G; Poggensee U; Steiner A; Müller O; Feldmeier H
    Ann Trop Med Parasitol; 1990 Oct; 84(5):457-65. PubMed ID: 2124097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver involvement in human schistosomiasis mansoni. Regression of immunological and biochemical disease markers after specific treatment.
    Zwingenberger K; Harms G; Feldmeier H; Müller O; Steiner A; Bienzle U
    Acta Trop; 1988 Sep; 45(3):263-75. PubMed ID: 2903628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Praziquantel in the treatment of hepatosplenic schistosomiasis: biochemical disease markers indicate deceleration of fibrogenesis and diminution of portal flow obstruction.
    Zwingenberger K; Richter J; Vergetti JG; Feldmeier H
    Trans R Soc Trop Med Hyg; 1990; 84(2):252-6. PubMed ID: 2117787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell phenotype alterations in hepatosplenic schistosomiasis mansoni normalize after chemotherapy.
    Zwingenberger K; Harms G; Vergetti de Siqueira JG; Correia Dacal AR; Jansen-Rosseck R; Bienzle U; Feldmeier H
    Immunobiology; 1989 Oct; 179(4-5):342-52. PubMed ID: 2515152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
    Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
    Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal.
    Gryseels B; Stelma FF; Talla I; van Dam GJ; Polman K; Sow S; Diaw M; Sturrock RF; Doehring-Schwerdtfeger E; Kardorff R
    Trop Geogr Med; 1994; 46(4 Spec No):209-19. PubMed ID: 7825223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating anodic antigen levels in serum before and after chemotherapy with praziquantel in schistosomiasis mansoni.
    de Jonge N; De Caluwé P; Hilberath GW; Krijger FW; Polderman AM; Deelder AM
    Trans R Soc Trop Med Hyg; 1989; 83(3):368-72. PubMed ID: 2515625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
    Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
    Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on schistosomiasis in western Kenya: II. Efficacy of praziquantel for treatment of schistosomiasis in persons coinfected with human immunodeficiency virus-1.
    Karanja DM; Boyer AE; Strand M; Colley DG; Nahlen BL; Ouma JH; Secor WE
    Am J Trop Med Hyg; 1998 Aug; 59(2):307-11. PubMed ID: 9715952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of circulating schistosome antigens in serum and urine of schistosomiasis patients and assessment of cure by a monoclonal antibody.
    Demerdash ZA; Mohamed SH; Shaker ZA; Hassan SI; el Attar GM; Din AH; Abadeer NI; Mansour MM
    J Egypt Soc Parasitol; 1995 Aug; 25(2):471-84. PubMed ID: 7665943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of one versus two doses of praziquantel on cure rate of Schistosoma mansoni infection and re-infection in Mayuge District, Uganda.
    Tukahebwa EM; Vennervald BJ; Nuwaha F; Kabatereine NB; Magnussen P
    Trans R Soc Trop Med Hyg; 2013 Jun; 107(6):397-404. PubMed ID: 23596262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immuno-epidemiology of Schistosoma mansoni infections in a recently exposed community in Senegal.
    Gryseels B; Stelma F; Talla I; Polman K; Van Dam G; Sow S; Diaw M; Sturrock RF; Decam C; Niang M
    Mem Inst Oswaldo Cruz; 1995; 90(2):271-6. PubMed ID: 8531670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity seven months after treatment with praziquantel.
    Mohamed-Ali Q; Doehring-Schwerdtfeger E; Abdel-Rahim IM; Schlake J; Kardorff R; Franke D; Kaiser C; Elsheikh M; Abdalla M; Schafer P
    Am J Trop Med Hyg; 1991 Apr; 44(4):444-51. PubMed ID: 1904198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour necrosis factor in hepatosplenic schistosomiasis.
    Zwingenberger K; Irschick E; Vergetti Siqueira JG; Correia Dacal AR; Feldmeier H
    Scand J Immunol; 1990 Feb; 31(2):205-11. PubMed ID: 2106723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cure rates and egg reduction in treatment of intestinal schistosomiasis with oxamniquine and praziquantel in Maniema, Zaire.
    Polderman AM; Gryseels B; De Caluwe P
    Trans R Soc Trop Med Hyg; 1988; 82(1):115-6. PubMed ID: 3140441
    [No Abstract]   [Full Text] [Related]  

  • 16. Two-year follow-up of Schistosoma mansoni infection and morbidity after treatment with different regimens of oxamniquine and praziquantel.
    Gryseels B; Nkulikyinka L
    Trans R Soc Trop Med Hyg; 1989; 83(2):219-28. PubMed ID: 2514474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni.
    Stelma FF; Talla I; Sow S; Kongs A; Niang M; Polman K; Deelder AM; Gryseels B
    Am J Trop Med Hyg; 1995 Aug; 53(2):167-70. PubMed ID: 7677219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating antigens for assessing cure in schistosomiasis mansoni.
    Madwar MA; Hassan MM; Strickland GT
    Trans R Soc Trop Med Hyg; 1988; 82(6):881-4. PubMed ID: 3151529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
    Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T regulatory cell levels decrease in people infected with Schistosoma mansoni on effective treatment.
    Watanabe K; Mwinzi PN; Black CL; Muok EM; Karanja DM; Secor WE; Colley DG
    Am J Trop Med Hyg; 2007 Oct; 77(4):676-82. PubMed ID: 17978070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.